-
ELVN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Enliven Therapeutics (ELVN)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 100.68 mm | 100.68 mm | 100.68 mm | 100.68 mm | 100.68 mm | 100.68 mm |
Cash burn (monthly) | (no burn) | (no burn) | 9.02 mm | 8.37 mm | 4.06 mm | 5.71 mm |
Cash used (since last report) | n/a | n/a | 39.50 mm | 36.62 mm | 17.79 mm | 24.98 mm |
Cash remaining | n/a | n/a | 61.18 mm | 64.06 mm | 82.88 mm | 75.70 mm |
Runway (months of cash) | n/a | n/a | 6.8 | 7.7 | 20.4 | 13.3 |
13F holders | Current |
---|---|
Total holders | 105 |
Opened positions | 19 |
Closed positions | 12 |
Increased positions | 42 |
Reduced positions | 24 |
13F shares | Current |
---|---|
Total value | 1.21 tn |
Total shares | 54.06 mm |
Total puts | 500.00 |
Total calls | 100.00 |
Total put/call ratio | 5.0 |
Largest owners | Shares | Value |
---|---|---|
Orbimed Advisors | 7.96 mm | $203.29 bn |
FMR | 6.30 mm | $160.80 bn |
Commodore Capital | 4.10 mm | $104.71 bn |
VR Adviser | 4.03 mm | $102.83 bn |
Venrock Healthcare Capital Partners III | 4.03 mm | $114.31 mm |
Fairmount Funds Management | 3.20 mm | $81.80 bn |
BlackRock | 2.94 mm | $75.00 bn |
5AM Ventures VI | 1.92 mm | $48.11 mm |
Vanguard | 1.92 mm | $49.05 bn |
5AM Venture Management | 1.75 mm | $44.75 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Feb 25 | Benjamin Hohl | Common Stock | Sell | Dispose S | No | Yes | 22.5244 | 1,000 | 22.52 k | 13,000 |
5 Feb 25 | Benjamin Hohl | Common Stock | Option exercise | Acquire M | No | Yes | 2.48 | 1,000 | 2.48 k | 14,000 |
5 Feb 25 | Benjamin Hohl | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.48 | 1,000 | 2.48 k | 146,056 |
27 Jan 25 | Benjamin Hohl | Common Stock | Sell | Dispose S | No | Yes | 21.5932 | 3,250 | 70.18 k | 13,000 |
27 Jan 25 | Benjamin Hohl | Common Stock | Option exercise | Acquire M | No | Yes | 2.48 | 3,250 | 8.06 k | 16,250 |
27 Jan 25 | Benjamin Hohl | Stock Option Common Stock | Option exercise | Dispose M | No | Yes | 2.48 | 3,250 | 8.06 k | 147,056 |
7 Jan 25 | Anish Patel | Common Stock | Sell | Dispose S | Yes | Yes | 24.6008 | 90 | 2.21 k | 336,644 |
7 Jan 25 | Anish Patel | Common Stock | Sell | Dispose S | Yes | Yes | 24.1686 | 6,577 | 158.96 k | 336,734 |
7 Jan 25 | Anish Patel | Common Stock | Sell | Dispose S | No | Yes | 24.561 | 1,440 | 35.37 k | 0 |
7 Jan 25 | Anish Patel | Common Stock | Sell | Dispose S | No | Yes | 24.1525 | 20,260 | 489.33 k | 1,440 |